Literature DB >> 16962209

Dose-dependent effects of peptide YY(3-36) on conditioned taste aversion in rats.

Prasanth K Chelikani1, Alvin C Haver, Roger D Reidelberger.   

Abstract

We used a conditioned taste aversion test to assess whether PYY(3-36) reduces food intake by producing malaise. Two-hour IV infusion of PYY(3-36) (8, 15, and 30 pmol/kg/min) at dark onset in non-food-deprived rats produced a dose-dependent inhibition of feeding and a conditioned aversion to the flavored chow paired with PYY(3-36) infusion. In food-deprived rats, PYY(3-36) at 2 and 4 pmol/kg/min inhibited intake of a flavored saccharin solution without producing conditioned taste aversion, whereas higher doses (8 and 15 pmol/kg/min) inhibited saccharin intake and produced taste aversion. These results suggest that anorexic doses of PYY(3-36) may produce a dose-dependent malaise in rats, which is similar to that reported for PYY(3-36) infusion in humans. Previous studies have shown that PYY(3-36) potently inhibits gastric emptying, and that gut distention can produce a conditioned taste aversion. Thus, PYY(3-36) may produce conditioned taste aversion in part by slowing gastric emptying.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16962209     DOI: 10.1016/j.peptides.2006.08.001

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  19 in total

Review 1.  Gut-brain nutrient signaling. Appetition vs. satiation.

Authors:  Anthony Sclafani
Journal:  Appetite       Date:  2012-06-01       Impact factor: 3.868

Review 2.  Role of gut nutrient sensing in stimulating appetite and conditioning food preferences.

Authors:  Anthony Sclafani; Karen Ackroff
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-03-21       Impact factor: 3.619

3.  Ghrelin signaling is not essential for sugar or fat conditioned flavor preferences in mice.

Authors:  Anthony Sclafani; Khalid Touzani; Karen Ackroff
Journal:  Physiol Behav       Date:  2015-05-21

4.  Effects of peripheral administration of a Neuromedin U receptor 2-selective agonist on food intake and body weight in obese mice.

Authors:  T Kaisho; H Nagai; T Asakawa; N Suzuki; H Fujita; K Matsumiya; N Nishizawa; Y Kanematsu-Yamaki; K Dote; J-I Sakamoto; T Asami; S Takekawa
Journal:  Int J Obes (Lond)       Date:  2017-07-31       Impact factor: 5.095

Review 5.  Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Authors:  Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

6.  Role of capsaicin-sensitive peripheral sensory neurons in anorexic responses to intravenous infusions of cholecystokinin, peptide YY-(3-36), and glucagon-like peptide-1 in rats.

Authors:  Roger Reidelberger; Alvin Haver; Krista Anders; Bettye Apenteng
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-12       Impact factor: 4.310

7.  Salivary peptide tyrosine-tyrosine 3-36 modulates ingestive behavior without inducing taste aversion.

Authors:  Maria D Hurtado; Valeriy G Sergeyev; Andres Acosta; Michael Spegele; Michael La Sala; Nickolas J Waler; Juan Chiriboga-Hurtado; Seth W Currlin; Herbert Herzog; Cedrick D Dotson; Oleg S Gorbatyuk; Sergei Zolotukhin
Journal:  J Neurosci       Date:  2013-11-20       Impact factor: 6.167

8.  Leptin extends the anorectic effects of chronic PYY(3-36) administration in ad libitum-fed rats.

Authors:  Suraj Unniappan; Timothy J Kieffer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-04-16       Impact factor: 3.619

9.  SGLT1 sugar transporter/sensor is required for post-oral glucose appetition.

Authors:  Anthony Sclafani; Hermann Koepsell; Karen Ackroff
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-01-20       Impact factor: 3.619

10.  Post-oral appetite stimulation by sugars and nonmetabolizable sugar analogs.

Authors:  Steven Zukerman; Karen Ackroff; Anthony Sclafani
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-08-07       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.